Atlas Trials

Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents

Clinical trial NCT05953389 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05953389
Sponsor
Bioprojet
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2023-12-20
Primary completion
2025-10-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.